Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALVOW
#11216
Alvotech Ordinary Shares
0.310
0
USD
+34.78%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+34.78%
Monthly Change
-18.42%
6 month change
-74.38%
Year Change
-79.33%
Previous Close
0.230
0
Open
0.310
0
Bid
Ask
Low
0.310
0
High
0.310
0
Volume
5
Markets
US Stock Market
Healthcare
ALVOW
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
248.65 M
266.82 M
301.81 M
312.02 M
1.13 B
Valuation ratios
Enterprise value
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
Price to book ratio
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.62
0.58
0.19
0.02
—
Return on equity %
0.91
0.59
0.56
0.1
—
Return on invested capital %
—
—
—
—
—
Gross margin %
25.2
98.68
153.17
114.75
—
Operating margin %
417.25
2.91
117.92
207.28
—
EBITDA margin %
—
—
—
—
—
Net margin %
618.55
4.52
392.6
73.99
—
Liquidity ratios
Quick ratio
0.95
0.46
1.69
1.16
—
Current ratio
1.38
0.75
2.35
1.89
—
Inventory turnover
0.9
2.2
1.83
1.35
—
Asset turnover
0.1
13.72
0.05
0.03
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
Working capital per share
—
—
—
—
—
Book value per share
—
—
—
—
—
News
Royce Smaller-Companies Growth Fund FY 2025: What Worked… And What Didn’t
Alvotech: Why FDA Delays Don't Break The Bull Case (NASDAQ:ALVO)
Teva Pharmaceuticals: Why It’s Time To Cash Out (Downgrade) (NYSE:TEVA)
Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance (ALVO)
Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again (NYSE:JNJ)
My Top 5 Biotech Stocks Big Pharma Could Buy Next
Alvotech (ALVO) Presents at Morgan Stanley 23rd Annual Global
Alvotech 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:ALVO)
Alvotech (ALVO) Q2 2025 Earnings Call Transcript
Johnson & Johnson Stock Just Proved The Bears Wrong Again (NYSE:JNJ)
Alvotech (ALVO) Q4 2024 Earnings Call Transcript
Why Organon Is A Top Pick For Income Investors (NYSE:OGN)